By Marisa Wong
Morgantown, W.Va., March 14 – Shanghai Fosun Pharmaceutical (Group) Co., Ltd. said it completed the issuance of RMB 1.25 billion of 4˝% five-year bonds on Tuesday.
The bonds were sold at par of RMB 100.
The coupon may be increased at the end of the third year, at which point investors will have a put option.
This is the company’s first tranche of corporate bonds for 2017. The company previously obtained approval to issue up to RMB 2 billion of corporate bonds.
The pharmaceutical company is a Shanghai-based member of the Hong Kong group Fosun International Ltd.
| Issuer: | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
|
| Issue: | Corporate bonds, 2017 first tranche
|
| Amount: | RMB 1.25 billion
|
| Maturity: | Five years
|
| Coupon: | 4˝%, may be increased at end of third year
|
| Price: | Par of RMB 100
|
| Put option: | At end of third year
|
| Settlement date: | March 14
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
